(Q45750923)

15 December 2017

title

Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection (English)

1 reference

15 December 2017

1 reference

1

1 reference

15 December 2017

author name string

Kraas W

2

1 reference

15 December 2017

Ross RS

3

1 reference

15 December 2017

Meisel H

4

1 reference

15 December 2017

Lechner S

5

1 reference

15 December 2017

Jung G

6

1 reference

15 December 2017

Roggendorf M

7

1 reference

15 December 2017

publication date

1 February 1999

1 reference

15 December 2017

published in

Journal of Hepatology

1 reference

15 December 2017

volume

30

1 reference

15 December 2017

issue

2

1 reference

15 December 2017

page(s)

177-184

1 reference

15 December 2017

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Vaccination of chimpanzees against infection by the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Persistence of HCV despite antibodies to both putative envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Genetic organization and diversity of the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Antigenic structure of the hepatitis C virus envelope 2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Anti-envelope antibodies in anti-hepatitis C virus (HCV) positive patients with and without liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Immune response to epitopes of hepatitis C virus (HCV) structural proteins in HCV-infected humans and chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Human recombinant antibodies specific for hepatitis C virus core and envelope E2 peptides from an immune phage display library

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980059-2

7 January 2021

10.1016/S0168-8278(99)80059-2

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017